An In-Depth Analysis of the Prevalence and Management of Vector-Borne Diseases in India: A Guide for Healthcare Professionals
OthersPage Navigation
Introduction
Vector-borne diseases (VBDs), including malaria, dengue, and chikungunya, present significant public health challenges in India.
Prevalence of VBDs
India carries a high burden of VBDs, with malaria and dengue being particularly widespread.
Management Strategies
Effective management involves integrated vector management (IVM) strategies, efficient surveillance systems, and community engagement.
Conclusion
Addressing VBDs in India requires a multifaceted approach, combining medical intervention and public health initiatives. Continued research and education are essential.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women
2.
Chronic pain and poor sleep are troublesome bed partners.
3.
Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals
4.
Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy
5.
New study elucidates obesity's role in fueling breast cancer progression
1.
A Closer Look at MCV Modules: Features, Functions, and Benefits
2.
Minimal Residual Disease Monitoring: Advances, Clinical Relevance, and Guideline-Based Perspectives
3.
Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making
4.
The Role of Calcium Corrections in Accurate Blood Test Results
5.
Oncology Drug Handling Near-Misses: Clinical Risks, Pathophysiology, and Guideline-Based Approaches
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
2.
Future of Hematology
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
4.
Efficient Management of First line ALK-rearranged NSCLC - Part V
5.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge